This study revealed that CsA and DQS did not differ significantly in their efficacy in improving most objective clinical indices for DED over 1-3 months of treatment. However, DQS demonstrated greater improvement in subjective patient-reported outcomes. Future RCTs should explore the long-term efficacy of these treatments.
Chen et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: